Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.74%2.01B | 4.26%1.77B | 0.25%505.6M | 11.89%459.46M | -1.41%407.87M | 7.62%394.73M | -2.51%1.7B | -1.84%504.32M | -9.37%410.64M | -2.70%413.7M |
| Cost of revenue | 15.41%1.15B | 3.43%995.02M | 3.53%282.87M | 2.66%241.23M | 0.06%232.63M | 7.64%238.29M | -16.10%962.06M | -15.70%273.21M | -17.33%234.97M | -18.88%232.49M |
| Gross profit | 11.60%862.26M | 5.35%772.63M | -3.62%222.74M | 24.23%218.23M | -3.29%175.24M | 7.60%156.43M | 23.81%733.37M | 21.86%231.11M | 4.02%175.67M | 30.73%181.21M |
| Operating expense | 18.77%693.37M | -1.21%583.79M | 5.98%154.91M | -0.55%143.17M | 2.41%147.52M | -11.85%138.19M | -6.83%590.94M | -1.77%146.17M | 0.74%143.97M | 4.52%144.05M |
| Operating profit | -10.57%168.89M | 32.59%188.85M | -20.15%67.82M | 136.73%75.05M | -25.40%27.72M | 260.49%18.25M | 440.13%142.43M | 107.93%84.94M | 22.09%31.7M | 4,556.64%37.16M |
| Net non-operating interest income (expenses) | -88.82%-5.27M | 26.98%-2.79M | 25.40%-602K | 28.46%-661K | 29.31%-721K | 24.67%-806K | 23.17%-3.82M | 24.08%-807K | 24.32%-924K | 21.24%-1.02M |
| Non-operating interest income | 5,633.33%344K | 0.00%6K | 0.00%3K | --0 | 0.00%3K | --0 | -14.29%6K | 0.00%3K | --0 | -25.00%3K |
| Non-operating interest expense | 100.72%5.61M | -26.94%2.8M | -25.31%605K | -28.46%661K | -29.23%724K | -24.67%806K | -23.15%3.83M | -24.02%810K | -24.32%924K | -21.25%1.02M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 720K | 0 | -21K | |||||||
| Less:Other special charges | ---720K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 103.16%563K | -1,770.22%-17.84M | -2,257.14%-151K | 0 | -522K | -17.17M | 109.35%1.07M | -99.49%7K | -51.36%982K | |
| Income before tax | -1.97%164.9M | 20.43%168.22M | -20.31%67.05M | 134.28%74.41M | -26.89%26.48M | 102.23%278K | 343.59%139.68M | 104.51%84.14M | 18.66%31.76M | 12,212.71%36.22M |
| Income tax | -0.03%68.61M | 19.51%68.63M | 54.40%23.19M | 60.79%21.05M | -46.71%9.75M | 32.94%14.63M | 75.92%57.42M | 297.29%15.02M | 36.09%13.09M | -65.69%18.3M |
| Net income | -3.31%96.29M | 21.07%99.59M | -36.55%43.85M | 185.82%53.36M | -6.65%16.72M | 38.78%-14.36M | 191.41%82.25M | 41.77%69.12M | 8.89%18.67M | 133.39%17.91M |
| Net income continuous operations | -3.31%96.29M | 21.07%99.59M | -36.55%43.85M | 185.81%53.36M | -6.64%16.72M | 38.78%-14.36M | 191.41%82.25M | 41.77%69.12M | 8.89%18.67M | 133.39%17.91M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -3.31%96.29M | 21.07%99.59M | -36.55%43.85M | 185.82%53.36M | -6.65%16.72M | 38.78%-14.36M | 191.41%82.25M | 41.77%69.12M | 8.89%18.67M | 133.39%17.91M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -3.31%96.29M | 21.07%99.59M | -36.55%43.85M | 185.82%53.36M | -6.65%16.72M | 38.78%-14.36M | 191.41%82.25M | 41.77%69.12M | 8.89%18.67M | 133.39%17.91M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -3.53%47.21 | 18.47%48.94 | -37.89%21.54 | 178.45%26.23 | -8.74%8.25 | 40.15%-7.08 | 190.51%41.31 | 39.50%34.68 | 4.43%9.42 | 133.27%9.04 |
| Diluted earnings per share | -2.81%46.63 | 18.00%47.98 | -38.06%21.14 | 172.91%25.7 | -9.17%8.2074 | 40.15%-7.08 | 189.09%40.66 | 38.79%34.13 | 8.89%9.417 | 133.26%9.0356 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |